Tandem Diabetes Care
TNDM
TNDM
291 hedge funds and large institutions have $2.63B invested in Tandem Diabetes Care in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 122 increasing their positions, 79 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more capital invested
Capital invested by funds: $2.12B → $2.63B (+$503M)
9% more funds holding
Funds holding: 268 → 291 (+23)
2.94% more ownership
Funds ownership: 110.01% → 112.95% (+2.9%)
Holders
291
Holding in Top 10
4
Calls
$121M
Puts
$9.18M
Top Buyers
1 | +$98M | |
2 | +$49.5M | |
3 | +$46.7M | |
4 |
Jennison Associates
New York
|
+$44.8M |
5 |
FAM
Fred Alger Management
New York
|
+$42.3M |
Top Sellers
1 | -$153M | |
2 | -$96.3M | |
3 | -$68.2M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.8M |
5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$15.3M |